anmelden
BX Swiss TOP 30 CHF
1.371,11
PKT
-4,74
PKT
-0,34
%
Handle Aktien, ETFs, Derivate & Kryptos ohne Ordergebühren (zzgl. Spreads) beim ‘Kostensieger’ finanzen.net zero (Stiftung Warentest 12/2025)
Werbung
Analysen zu BX Swiss TOP 30 CHF-Werten
| Datum | Rating | Analyst | |
|---|---|---|---|
| 03.05.16 | Swiss Re overweight | JP Morgan Chase & Co. | |
| 03.05.16 | ABB (Asea Brown Boveri) Sell | Goldman Sachs Group Inc. | |
| 29.04.16 | Swiss Re kaufen | DZ-Bank AG | |
| 28.04.16 | Richemont Outperform | Robert W. Baird & Co. Incorporated | |
| 28.04.16 | Novartis Neutral | UBS AG | |
| 27.04.16 | Nestlé Outperform | Robert W. Baird & Co. Incorporated | |
| 27.04.16 | Holcim Neutral | JP Morgan Chase & Co. | |
| 27.04.16 | UBS buy | Goldman Sachs Group Inc. | |
| 27.04.16 | UBS Neutral | Goldman Sachs Group Inc. | |
| 26.04.16 | Novartis Outperform | Bernstein Research | |
| 26.04.16 | Roche Outperform | Bernstein Research | |
| 26.04.16 | Novartis buy | HSBC | |
| 26.04.16 | ABB (Asea Brown Boveri) Sell | Goldman Sachs Group Inc. | |
| 26.04.16 | ABB (Asea Brown Boveri) Underperform | BNP PARIBAS | |
| 26.04.16 | Novartis Neutral | BNP PARIBAS | |
| 25.04.16 | Holcim overweight | Morgan Stanley | |
| 25.04.16 | Holcim Neutral | Goldman Sachs Group Inc. | |
| 25.04.16 | Novartis overweight | JP Morgan Chase & Co. | |
| 22.04.16 | Novartis Underweight | Morgan Stanley | |
| 22.04.16 | Richemont buy | UBS AG | |
| 22.04.16 | Holcim market-perform | Bernstein Research | |
| 22.04.16 | Novartis Equal weight | Barclays Capital | |
| 21.04.16 | ABB (Asea Brown Boveri) Sell | Citigroup Corp. | |
| 21.04.16 | ABB (Asea Brown Boveri) Equal-Weight | Morgan Stanley | |
| 21.04.16 | Holcim Sell | Baader Wertpapierhandelsbank | |
| 21.04.16 | ABB (Asea Brown Boveri) Hold | Société Générale Group S.A. (SG) | |
| 21.04.16 | Novartis buy | Joh. Berenberg, Gossler & Co. KG (Berenberg Bank) | |
| 21.04.16 | ABB (Asea Brown Boveri) Sell | Joh. Berenberg, Gossler & Co. KG (Berenberg Bank) | |
| 21.04.16 | Holcim Hold | Kepler Cheuvreux | |
| 21.04.16 | ABB (Asea Brown Boveri) Neutral | JP Morgan Chase & Co. | |
| 21.04.16 | UBS Neutral | UBS AG | |
| 20.04.16 | Roche overweight | Morgan Stanley | |
| 20.04.16 | ABB (Asea Brown Boveri) Halten | Independent Research GmbH | |
| 20.04.16 | Roche overweight | JP Morgan Chase & Co. | |
| 20.04.16 | Novartis overweight | JP Morgan Chase & Co. | |
| 19.04.16 | Holcim Neutral | BNP PARIBAS | |
| 19.04.16 | Givaudan Sell | Société Générale Group S.A. (SG) | |
| 19.04.16 | Novartis Neutral | Goldman Sachs Group Inc. | |
| 18.04.16 | Zurich Insurance Neutral | Citigroup Corp. | |
| 18.04.16 | Roche buy | UBS AG |